9
Apr
2025

Glenmark Life Sciences

Exhibitor at CPHI Japan 2025 stand 4V-21
About Us

Glenmark Life Sciences Limited, is a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas such as cardiovascular disease, central nervous system disease, pain management and diabetes. 

The company is increasingly providing CDMO services to a range of multinational and specialty pharmaceutical companies. It has a diversified portfolio of more than 137 molecules and supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world (ROW)....

  • IN
  • 2020
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Contact info
Event information
CPHI Japan 2025
  • 09 Apr 2025 – 11 Apr 2025
  • East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
  • Visit us at stand 4V-21